Similar articles for PMID: 21414942

Year	Number of Results
1947	1
1983	1
1996	1
1998	1
1999	2
2002	1
2004	2
2005	3
2006	6
2007	7
2008	3
2009	5
2010	5
2011	2
2012	7
2013	10
2014	6
2015	6
2016	5
2017	7
2018	4
2020	1
2021	1

1

In Vitro Screening Methods To Assess the Potential of In Vivo Precipitation of Injectable Formulations upon Intravenous Administration.

Sheth AR. Sheth AR. PDA J Pharm Sci Technol. 2011 Jan-Feb;65(1):71-80. PDA J Pharm Sci Technol. 2011. PMID: 21414942

2

In-vitro prediction of bioavailability following extravascular injection of poorly soluble drugs: an insight into clinical failure and the role of delivery systems.

Wu Z, Hassan D, Shaw JP. Wu Z, et al. J Pharm Pharmacol. 2013 Oct;65(10):1429-39. doi: 10.1111/jphp.12114. Epub 2013 Jul 24. J Pharm Pharmacol. 2013. PMID: 24028610 Review.

3

Importance of early characterization of physicochemical properties in developing high-dose intravenous infusion regimens for poorly water-soluble compounds.

Jain A, Zheng W, Garad S, Weaver M, Panicucci R. Jain A, et al. PDA J Pharm Sci Technol. 2010 Nov-Dec;64(6):517-26. PDA J Pharm Sci Technol. 2010. PMID: 21502062

4

In vitro methods to assess drug precipitation.

Dai WG. Dai WG. Int J Pharm. 2010 Jun 30;393(1-2):1-16. doi: 10.1016/j.ijpharm.2010.03.040. Epub 2010 Mar 27. Int J Pharm. 2010. PMID: 20347943 Review.

5

In vitro method for detecting precipitation of parenteral formulations after injection.

Yalkowsky SH, Valvani SC, Johnson BW. Yalkowsky SH, et al. J Pharm Sci. 1983 Sep;72(9):1014-7. doi: 10.1002/jps.2600720911. J Pharm Sci. 1983. PMID: 6631683

6

Buffer capacity and precipitation control of pH solubilized phenytoin formulations.

Alvarez-Núñez FA, Yalkowsky SH. Alvarez-Núñez FA, et al. Int J Pharm. 1999 Aug 5;185(1):45-9. doi: 10.1016/s0378-5173(99)00129-5. Int J Pharm. 1999. PMID: 10425364

7

Study of drug supersaturation for rational early formulation screening of surfactant/co-solvent drug delivery systems.

Stillhart C, Cavegn M, Kuentz M. Stillhart C, et al. J Pharm Pharmacol. 2013 Feb;65(2):181-92. doi: 10.1111/j.2042-7158.2012.01586.x. Epub 2012 Sep 13. J Pharm Pharmacol. 2013. PMID: 23278685

8

In vitro hemolysis: guidance for the pharmaceutical scientist.

Amin K, Dannenfelser RM. Amin K, et al. J Pharm Sci. 2006 Jun;95(6):1173-6. doi: 10.1002/jps.20627. J Pharm Sci. 2006. PMID: 16639718

9

Studies of the precipitation pattern of paclitaxel in intravenous infusions and rat plasma using laser nephelometry.

El Nemr S, Al-Najjar BY, Omer HK, Elhissi AMA, Alhnan MA. El Nemr S, et al. Pharm Dev Technol. 2018 Jan;23(1):67-75. doi: 10.1080/10837450.2017.1345940. Epub 2017 Jul 19. Pharm Dev Technol. 2018. PMID: 28696155

10

Studies in phlebitis VIII: evaluations of pH solubilized intravenous dexverapamil formulations.

Simamora P, Pinsuwan S, Surakitbanharn Y, Yalkowsky SH. Simamora P, et al. PDA J Pharm Sci Technol. 1996 Mar-Apr;50(2):123-8. PDA J Pharm Sci Technol. 1996. PMID: 8935779

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed